1. Home
  2. ELEV vs BLIN Comparison

ELEV vs BLIN Comparison

Compare ELEV & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • BLIN
  • Stock Information
  • Founded
  • ELEV 2019
  • BLIN 2000
  • Country
  • ELEV United States
  • BLIN United States
  • Employees
  • ELEV N/A
  • BLIN N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • BLIN EDP Services
  • Sector
  • ELEV Health Care
  • BLIN Technology
  • Exchange
  • ELEV Nasdaq
  • BLIN Nasdaq
  • Market Cap
  • ELEV 18.1M
  • BLIN 16.5M
  • IPO Year
  • ELEV 2021
  • BLIN 2007
  • Fundamental
  • Price
  • ELEV $0.32
  • BLIN $1.59
  • Analyst Decision
  • ELEV Buy
  • BLIN Strong Buy
  • Analyst Count
  • ELEV 6
  • BLIN 1
  • Target Price
  • ELEV $2.94
  • BLIN $4.62
  • AVG Volume (30 Days)
  • ELEV 753.5K
  • BLIN 45.1K
  • Earning Date
  • ELEV 08-05-2025
  • BLIN 05-15-2025
  • Dividend Yield
  • ELEV N/A
  • BLIN N/A
  • EPS Growth
  • ELEV N/A
  • BLIN N/A
  • EPS
  • ELEV N/A
  • BLIN N/A
  • Revenue
  • ELEV N/A
  • BLIN $15,465,000.00
  • Revenue This Year
  • ELEV N/A
  • BLIN $4.69
  • Revenue Next Year
  • ELEV N/A
  • BLIN $10.70
  • P/E Ratio
  • ELEV N/A
  • BLIN N/A
  • Revenue Growth
  • ELEV N/A
  • BLIN 1.30
  • 52 Week Low
  • ELEV $0.22
  • BLIN $0.76
  • 52 Week High
  • ELEV $3.77
  • BLIN $2.80
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 49.38
  • BLIN 46.17
  • Support Level
  • ELEV $0.29
  • BLIN $1.49
  • Resistance Level
  • ELEV $0.32
  • BLIN $1.62
  • Average True Range (ATR)
  • ELEV 0.02
  • BLIN 0.07
  • MACD
  • ELEV 0.00
  • BLIN -0.01
  • Stochastic Oscillator
  • ELEV 59.01
  • BLIN 47.62

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: